Important topics include: Potential drug interactions between GLP-1 medications and DMARDs Monitoring strategies for both conditions Whether weight loss might improve RA symptoms or treatment response Cardiovascular risk reduction strategies Safety considerations including contraindications (personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Patients should not discontinue or modify DMARD therapy based on unproven theories about GLP-1 medications treating RA
TB-500 targets the cell-migration axis of tendon healing
He truly goes above and beyond to find the best treatment plan and has been incredibly thorough and thoughtful in managing my care
Water, Glutathione, Glycerin, Methylpropanediol, Alpha- Arbutin, Carboxymethyl Chitosan, Glycyrrhiza Glabra (licorice) Root Extract, Peg-12 Dimethicone Crosspolymer, Carbomer, Argining, Hydroxyethylcellulose, 2-Bromo-2- Nitropropane-1, 3-Diol
adults are using some type of GLP-1 drug
These features may suggest systemic bleeding disorders or other serious conditions